TUZEMTY

Serial Number 98849065
Registration 7787291
700

Registration Progress

Application Filed
Nov 12, 2024
Under Examination
Approved for Publication
Jan 28, 2025
Published for Opposition
Mar 18, 2025
Registered
May 6, 2025

Trademark Image

TUZEMTY

Basic Information

Serial Number
98849065
Registration Number
7787291
Filing Date
November 12, 2024
Registration Date
May 6, 2025
Published for Opposition
March 18, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 6, 2025
Registration
Registered
Classes
005

Rights Holder

N.V. ORGANON

99
Address
KLOOSTERSTRAAT 6
OSS 5349AB
NL

Ownership History

N.V. ORGANON

Original Applicant
99
OSS NL

N.V. ORGANON

Owner at Publication
99
OSS NL

N.V. ORGANON

Original Registrant
99
OSS NL

Legal Representation

Attorney
James A. Thomas

USPTO Deadlines

Next Deadline
2105 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-06)
Due Date
May 06, 2031
Grace Period Ends
November 06, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
May 6, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 6, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 18, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 18, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 12, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 8, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of bone diseases, metabolic diseases, and cancer and complications associated with the foregoing.

Classification

International Classes
005